The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir

The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir

Background. There is a mounting evidence in the scientific literature that susceptibility to SARS-CoV-2 infection could vary. The severity of COVID-19 symptoms can  range from asymptomatic to severe respiratory failure, requiring prolonged artificial ventilation. The underlying causes of this range...

Full description

Bibliographic Details
Main Authors: Sh. P. Abdullaev, N. P. Denisenko, I. I. Temirbulatov, A. A. Kachanova, S. N. Tuchkova, E. V. Mikhaylenko, A. V. Kryukov, T. T. Valiev, K. B. Mirzaev, D. A. Sychev
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2024-01-01
Series:Acta Biomedica Scientifica
Subjects:
sensitivity to covid-19
severity of covid-19
covid-19 etiotropic therapy
favipiravir
remdesivir
rs11385942
rs657152
polymorphisms
Online Access:https://www.actabiomedica.ru/jour/article/view/4489

Internet

https://www.actabiomedica.ru/jour/article/view/4489

Similar Items